Text Size

Sharable Knowledge Mining Platform

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01178801
First received: May 30, 2010
Last updated: August 9, 2010
Last verified: July 2010
History of Changes
  Purpose

As a result of increasing adoption of health information systems in hospitals, more and more health records can be gathered and accumulated in the healthcare data repository. For this reason, the opportunity of analyzing and mining the healthcare data for quality improvement is increasing and becoming more and more important.

The purpose of the project is to gather the clinical data relevant to liver cancer, and adopt the knowledge discovery and mining modules in information technology (IT) for analyzing and discovering the knowledge from the gathered clinical data.

We can analyze the gathered clinical data for comparing the outcomes of different treatment strategies, finding out new diagnosis and staging criteria and factors, and other hidden knowledge included in the clinical data.

Afterwards, the discovered results and the mining algorithms can be shared though the sharable knowledge mining platform provided by our project.


Condition
Liver Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Sharable Knowledge Mining Platform for Clinical Data Extraction, and Medical Knowledge and Mining Services Sharing

Resource links provided by NLM:

MedlinePlus related topics: Cancer Liver Cancer
U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • the relationship between the clinical data and the decision of treatment strategies [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 10000
Study Start Date: March 2010
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
liver cancer
Clinical data of patients with liver cancer

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with liver cancer. (ICD9 Code is 155.0)

Criteria

Inclusion Criteria:

  • Clinical data of patients with liver cancer. (ICD9 Code is 155.0)
  • Males and females
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01178801

Contacts
Contact: Feipei Lai +886-2-33665001 flai@ntu.edu.tw

Locations
Taiwan
National Taiwan University Recruiting
Taipei, Taiwan
Contact: Feipei Lai, PhD     +886-2-33665001     flai@ntu.edu.tw    
Sponsors and Collaborators
National Taiwan University Hospital
National Science Council, Taiwan
Investigators
Study Chair: Feipei Lai, Ph.D. National Taiwan University,Graduate Institute of Biomedical Electronics
  More Information

No publications provided

Responsible Party: Feipei Lai/Professor & Director, National Taiwan University,Graduate Institute of Biomedical Electronics and Bioinformatics
ClinicalTrials.gov Identifier: NCT01178801     History of Changes
Other Study ID Numbers: 201002032R
Study First Received: May 30, 2010
Last Updated: August 9, 2010
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
liver cancer
data mining
knowledge discovering
The clinical data of the patients with liver cancer.

Additional relevant MeSH terms:
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
 Neoplasms
Digestive System Diseases
Liver Diseases

ClinicalTrials.gov processed this record on June 18, 2013